Denosumab

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5680 publications

Denosumab-functionalized nanoparticles target macrophages to mitigate age-related osteoarthritis and osteoporosis.

Denosumab-functionalized nanoparticles target macrophages to mitigate age-related osteoarthritis and osteoporosis.

Journal: Journal of materials chemistry. B
Published: January 22, 2026

Impact of Osteoporosis Medications on Postoperative Complications Following Total Knee Arthroplasty.

Impact of Osteoporosis Medications on Postoperative Complications Following Total Knee Arthroplasty.

Journal: The journal of knee surgery
Published: January 16, 2026

Denosumab treatment after percutaneous vertebroplasty for osteoporotic vertebral compression fractures: Long-term follow-up of pain relief, bone mineral density changes, and risk of refracture.

Denosumab treatment after percutaneous vertebroplasty for osteoporotic vertebral compression fractures: Long-term follow-up of pain relief, bone mineral density changes, and risk of refracture.

Journal: Journal of orthopaedic surgery (Hong Kong)
Published: January 13, 2026

Atypical femur fracture in denosumab treatment and as a rare differential diagnosis to nerve root affection

Atypical femur fracture in denosumab treatment and as a rare differential diagnosis to nerve root affection

Journal: Ugeskrift for laeger
Published: January 05, 2026

Refined ADA testing strategy to overcome sRANKL interference in denosumab/FKS518 immunogenicity assessment.

Refined ADA testing strategy to overcome sRANKL interference in denosumab/FKS518 immunogenicity assessment.

Journal: Bioanalysis
Published: December 29, 2025

Bone-Targeted Platinum Nanoframework Prevents Postmenopausal Osteoporosis via Transmembrane Protein 16A Channel Blockade and Reactive Oxygen Species Scavenging.

Bone-Targeted Platinum Nanoframework Prevents Postmenopausal Osteoporosis via Transmembrane Protein 16A Channel Blockade and Reactive Oxygen Species Scavenging.

Journal: ACS nano
Published: December 27, 2025

The Silent Surge: A Case of Rhabdomyolysis-Induced Hypercalcemia.

The Silent Surge: A Case of Rhabdomyolysis-Induced Hypercalcemia.

Journal: The American journal of case reports
Published: December 25, 2025

Development and validation of a method for quantitation of CTx-1 for the assessment of biosimilarity of FKS518, a denosumab biosimilar.

Development and validation of a method for quantitation of CTx-1 for the assessment of biosimilarity of FKS518, a denosumab biosimilar.

Journal: Bioanalysis
Published: December 25, 2025

Safety and Synergy of Capmatinib Plus Stereotactic Radiotherapy in MET Exon 14-Mutated Non-Small Cell Lung Cancer: A Case Report.

Safety and Synergy of Capmatinib Plus Stereotactic Radiotherapy in MET Exon 14-Mutated Non-Small Cell Lung Cancer: A Case Report.

Journal: Cureus
Published: December 20, 2025

Multiple brown tumours in the maxillofacial region as the initial presentation of primary hyperparathyroidism.

Multiple brown tumours in the maxillofacial region as the initial presentation of primary hyperparathyroidism.

Journal: BMJ case reports
Published: December 19, 2025

Denosumab Versus Bisphosphonates in Glucocorticoid-Induced Osteoporosis: A Systematic Review.

Denosumab Versus Bisphosphonates in Glucocorticoid-Induced Osteoporosis: A Systematic Review.

Journal: Cureus
Published: December 17, 2025

Long-term effect on bone mineral density of denosumab in the treatment of hyperpituitarism driven osteoporosis: an exploratory study.

Long-term effect on bone mineral density of denosumab in the treatment of hyperpituitarism driven osteoporosis: an exploratory study.

Journal: Pituitary
Published: December 13, 2025
Showing 1-12 of 5,680

Last Updated: 02/24/2026